Long-term outcome in children with Hodgkin's lymphoma: The United Kingdom Children's Cancer Study Group HD82 trial

European Journal of Cancer

Volumn 43, Issue 7, 2007, Pages 1171-1179

  Capra, Michael ^a   Hewitt, Martin ^b   Radford, Martin ^c   Hayward, Janis ^d   Weston, Claire L ^d   Machin, David ^d,e  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Chemotherapy; Childhood; Hodgkin's lymphoma; Late effects; Radiotherapy; Second malignancy

Indexed keywords

CHLORAMBUCIL; PREDNISOLONE; PROCARBAZINE; VINBLASTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SCANDENTIA; SURVIVAL TIME; UNITED KINGDOM;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHLORAMBUCIL; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INFANT; INFANT, NEWBORN; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PREDNISOLONE; PROCARBAZINE; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; VINBLASTINE;

EID: 34247092769     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.01.023     Document Type: Article

References (30)

1. Teillet F., and Schweisguth O. Hodgkin's disease in children. Notes on diagnosis and prognosis based on experiences with 72 cases in children. Clin Pediatr (Phila) 8 (1969) 698-704
2. Donaldson S.S., Glatstein E., Rosenberg S.A., and Kaplan H.S. Pediatric Hodgkin's disease. II. Results of therapy. Cancer 37 (1976) 2436-2447
3. Botnick L.E., Goodman R., Jaffe N., Filler R., and Cassady J.R. Stages I-III Hodgkin's disease in children: results of staging and treatment. Cancer 39 (1977) 599-603
4. Jenkin D., Freedman M., McClure P., Peters V., Saunders F., and Sonley M. Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report. Cancer 44 (1979) 80-86
5. Lange B., and Littman P. Management of Hodgkin's disease in children and adolescents. Cancer 51 (1983) 1371-1377
6. Mertens A., Yasui Y., Neglia J.P., et al. Late mortality experience in five year survivors of childhood adolescent cancer: the childhood cancer survivor study. JCO 19 (2001) 3163-3172
7. Neglia J.P., Friedman D.L., Yasui Y., et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93 (2001) 618-629
8. Ruhl U., Albrecht M., Dieckmann K., et al. Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial. Int J Radiat Oncol Biol Phys 51 Dec 1 (2001) 1209-1218
9. Nachman J.B., Sposto R., Herzog P., et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 20 (2002) 3765-3771
10. Barrett A., Crennan E., Barnes J., Martin J., and Radfors M. Treatment of clinical stage I Hodgkin's disease by local radiation therapy alone. A United Kingdom Childrens Cancer Study Group study. Cancer 66 (1990) 670-674
11. Shankar A.G., Ashley S., Radford M., Barrett A., Wright D., and Pinkerton C.R. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group. J Clin Oncol 15 (1997) 2622-2630
12. Carbone P.P., Kaplan H.S., Musshoff K., Smithers D.W., and Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31 (1971) 1860-1861
13. Lukes R.J., and Butler J.J. The pathology and nomenclature of Hodgkin's disease. Cancer Res 26 (1966) 1063-1083
14. Sposto R. Cure model analysis in cancer: an application to data from the Children's Cancer Group. Stat Med 21 (2002) 293-312
15. StataCorp. Stata statistical software: release 8.2 (2003), Stata Press, College Station (TX)
16. Oberlin O., Leverger G., Pacquement H., et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. J Clin Oncol 10 (1992) 1602-1608
17. Schellong G., Bramswig J.H., Schwarze E.W., and Wannenmacher M. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies. Bull Cancer 75 (1988) 41-51
18. Weiner M.A., Leventhal B., Brecher M.L., et al. Randomized study of intensive MOPP-ABVD with or without low dose total-nodal radiotherapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 15 (1997) 2769-2779
19. Loeffler M., Hasenclever D., Sextro M., et al. Meta analysis of chemotherapy versus combination treatment trials in Hodgkins disease: International Database on Hodgkin's Disease Overview Study Group. J Clin Oncol 16 (1998) 818-829
20. Schellong G., Bramswig J., Ludwig R., et al. Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82. Klin Padiatr 198 (1986) 137-146
21. Sklar C., Whitton J., Mertens A., et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85 (2000) 3227-3232
22. Hancock S.L., Donaldson S.S., and Hoppe R.T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11 (1993) 1208-1215
23. Bossi G., Cerveri I., Volpini E., et al. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease. Ann Oncol 8 (1997) 519-524
24. Bhatia S., Robinson L.L., Oberlin O., et al. Breast cancer and other second neoplasms neoplasms after childhood Hodgkin's disease. N Engl J Med 334 (1996) 745-751
25. Jenkin D., Doyle J., Berry M., et al. Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. Med Pediatr Oncol 18 (1990) 265-272
26. Hunger S.P., Link M.P., and Donaldson S.S. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol 12 (1994) 2160-2166
27. Fryer C.J., Hutchinson R.J., Krailo M., et al. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group. J Clin Oncol 12 (1990) 1971-1980
28. Meadows A.T., Obringer A.C., Marrero O., et al. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Med Pediatr Oncol 17 (1989) 477-484
29. Bhatia S., Yasui S., Robison L.L., et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21 (2003) 4386-4394
30. Wolden S.L., Lamborn K.R., Cleary S.F., Tate D.J., and Donaldson S.S. Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16 (1998) 536-544